Evidence map›Paper›PMID 36419161›Full record

ArticleBreast cancer research : BCR2022

Intraoperative electron radiotherapy in early invasive ductal breast cancer: 6-year median follow-up results of a prospective monocentric registry.

Catherine Philippson, Samuel Larsen, Stéphane Simon, Christophe Vandekerkhove, Alex De Caluwe, Dirk Van Gestel, Marie Chintinne, Isabelle Veys, Filip De Neubourg, Danièle Noterman and 3 more

Open access · goldAbstract read
In one paragraph

Article in Breast cancer research : BCR, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. SAFE-IOERT prospective study: clinical outcomes of exclusive intraoperative radiotherapy in early breast cancer according to molecular subtype and tumor-infiltrating lymphocytes.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Catherine Philippson *Department of Radiation Oncology, Jules Bordet Institute, 1000, Brussels, Belgium. catherine.philippson@bordet.be.
Samuel Larsen *Faculté de Médecine, Université Libre de Bruxelles, 1070, Brussels, Belgium.
Stéphane SimonDepartment of Radiation Oncology, Jules Bordet Institute, 1000, Brussels, Belgium.
Christophe VandekerkhoveDepartment of Radiophysics, Jules Bordet Institute, 1000, Brussels, Belgium.
Alex De CaluweDepartment of Radiation Oncology, Jules Bordet Institute, 1000, Brussels, Belgium.
Dirk Van GestelDepartment of Radiation Oncology, Jules Bordet Institute, 1000, Brussels, Belgium.
Marie ChintinneDepartment of Pathology, Jules Bordet Institute, 1000, Brussels, Belgium.
Isabelle VeysDepartment of Surgery, Jules Bordet Institute, 1000, Brussels, Belgium.
Filip De NeubourgDepartment of Surgery, Jules Bordet Institute, 1000, Brussels, Belgium.
Danièle NotermanDepartment of Surgery, Jules Bordet Institute, 1000, Brussels, Belgium.
Mirela RomanDepartment of Surgery, Jules Bordet Institute, 1000, Brussels, Belgium.
Jean-Marie NogaretDepartment of Surgery, Jules Bordet Institute, 1000, Brussels, Belgium.
Antoine DesmetDepartment of Radiation Oncology, Jules Bordet Institute, 1000, Brussels, Belgium.
Institut Jules Bordet · BEUniversité Libre de Bruxelles · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntraoperative electron radiotherapy (IOERT) can be used to treat early breast cancer during the conservative surgery thus enabling shorter overall treatment times and reduced irradiation of organs at risk. We report on our first 996 patients enrolled prospectively in a registry trial.

methodsAt Jules Bordet Institute, from February 2010 onwards, patients underwent partial IOERT of the breast. Women with unifocal invasive ductal carcinoma, aged 40 years or older, with a clinical tumour size ≤ 20 mm and tumour-free sentinel lymph node (on frozen section and immunohistochemical analysis). A 21 Gy dose was prescribed on the 90% isodose line in the tumour bed with the energy of 6 to 12 MeV (Mobetron®-IntraOp Medical).

resultsThirty-seven ipsilateral tumour relapses occurred. Sixteen of those were in the same breast quadrant. Sixty patients died, and among those, 12 deaths were due to breast cancer. With 71.9 months of median follow-up, the 5-year Kaplan-Meier estimate of local recurrence was 2.7%.

conclusionsThe rate of breast cancer local recurrence after IOERT is low and comparable to published results for IORT and APBI. IOERT is highly operator-dependent, and appropriate applicator sizing according to tumour size is critical. When used in a selected patient population, IOERT achieves a good balance between tumour control and late radiotherapy-mediated toxicity morbidity and mortality thanks to insignificant irradiation of organs at risk.

Indexed as

Breast NeoplasmsMastectomy, SegmentalElectronsFemaleFollow-Up StudiesHumansNeoplasm Recurrence, LocalProspective StudiesRegistriesAccelerated partial breast irradiation (APBI)Early stage breast cancerIntraoperative electron radiotherapy (IOERT)

Identifiers

PMID36419161
PMCPMC9685863
OpenAlexW4309883504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.